GlassScriptPhysician profile
Julie Washko
NPI 1639828460
$11,846.22
in general payments reported to CMS, 2019-2025
49 companies · $3,976 in 2025
The $3,976 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,330 · 2023: $3,521 · 2024: $3,019 · 2025: $3,976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,516.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,775.06 | 2022-2025 | |
| Novo Nordisk INC | $1,374.13 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $849.35 | 2022-2025 | |
| Pfizer INC. | $833.11 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $697.30 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $578.18 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $534.73 | 2022-2025 | Jardiance, Mounjaro, Reyvow |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $494.61 | 2022-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $433.80 | 2022-2025 | Trintellix |
| Antares Pharma, INC. | $402.61 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Kowa Pharmaceuticals America, INC. | $281.00 | 2022-2025 | Zoryve, Livalo, Seglentis |
| Axsome Therapeutics, INC. | $270.85 | 2023-2025 | Auvelity, Symbravo |
| Amgen INC. | $230.98 | 2022-2025 | Otezla, Repatha, Otezla |
| Aimmune Therapeutics, INC. | $226.14 | 2024-2025 | Zenpep |
| Lundbeck LLC | $204.96 | 2022-2025 | Rexulti |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $193.61 | 2024-2025 | Voquezna |
| Shield Therapeutics INC | $171.66 | 2023-2024 | Accrufer |
| Halozyme INC | $154.91 | 2023 | |
| Merck Sharp & Dohme LLC | $152.29 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Exact Sciences Corporation | $150.56 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Xeris Pharmaceuticals, INC. | $146.91 | 2022-2024 | Gvoke Hypopen |
| Otsuka America Pharmaceutical, INC. | $114.15 | 2022-2025 | Rexulti |
| Sumitomo Pharma America, INC. | $111.98 | 2023-2025 | Gemtesa |
| Ucb, INC. | $107.04 | 2023 | Nayzilam, Briviact |
| Nestle Healthcare Nutrition INC. | $103.44 | 2022-2023 | |
| Astellas Pharma US INC | $96.70 | 2024-2025 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $89.92 | 2022 | |
| Tolmar, INC. | $85.76 | 2024-2025 | Jatenzo |
| Esperion Therapeutics, INC. | $85.70 | 2024-2025 | Nexletol |
| Teleflex LLC | $85.00 | 2023-2025 | Urolift, Barrigel |
| Teva Pharmaceuticals USA, INC. | $73.09 | 2022-2024 | Austedo Xr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.66 | 2022-2024 | Jardiance, Synjardy |
| Madrigal Pharmaceuticals | $67.53 | 2025 | Rezdiffra |
| Ibsa Pharma INC. | $63.30 | 2023-2025 | Tirosint, Licart, Flector |
| Vanda Pharmaceuticals INC. | $61.26 | 2025 | Fanapt |
| Sanofi-Aventis U.S. LLC | $59.61 | 2022-2023 | |
| Verona Pharma, INC. | $56.11 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $55.77 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $44.12 | 2025 | Caplyta |
| Almatica Pharma LLC | $41.29 | 2023 | Loreev Xr |
| Merz North America, INC. | $40.54 | 2023 | Xeomin |
| Daiichi Sankyo INC. | $33.64 | 2022 | |
| Dexcom, INC. | $31.85 | 2024-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $26.41 | 2022 | |
| Supernus Pharmaceuticals, INC. | $23.65 | 2025 | Tlando, Xyosted, Qelbree |
| Janssen Pharmaceuticals, INC | $17.42 | 2022 | |
| Philips North America LLC | $16.50 | 2024 | (Ak6) Vest Therapy |
| Boston Scientific Corporation | $14.61 | 2024 | Watchman Flx |
| Radius Health, INC. | $14.42 | 2024 | Tymlos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Washko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.